The global Cell Line Development market is anticipated to grow at a CAGR of 9.6% during the forecast period (2023-2030). Cell line development is a process of developing highly productive, stable cell lines essential for the production and manufacturing of bio-therapeutics. These are single-celled derived and used to produce vaccines, monoclonal antibodies, and fusion proteins. It can be used in the treatment of chronic diseases such as arthritis, diabetes, and cancer. Hence, the market players are focusing on research and introducing new and more advanced solutions for cell development. For instance, in October 2022, Great Bay Bio announces the official launch of its self-developed AI-enabled site-specific integration platform for cell line development (CLD), AlfaCell. This platform has pioneered to integrate GBB's proprietary AI technologies with cell line development techniques, which is a milestone in the AI-enabled bioprocessing development. this platform intelligently combines the site-specific integration (SSI) technology and AI-enabled cell selection to accurately insert the target genes into stable, high expression and high quality specific "hot spot", which significantly reduces time, effort, and cost in the CLD process. The clients' data showed that the AlfaCell platform has significant advantages in the areas of "yield, stability, simplicity and uniformity" for CLD.
Browse the full report description of “Cell Line Development Market Size, Share & Trends Analysis Report by Product Type (Reagent and Media, Equipment and Accessories and Consumables), by Source Type (Mammalian and Non-mammalian), by End User (Biopharmaceutical and Biotechnology Companies, Contract Research Organizations and Academics and Research Institutes) and by Cell Line (Recombinant, Hybridomas, Continuous and Primary), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/cell-line-development-market
Further, increasing strategic initiatives by the key players and investing activities in research and development is another factor driving the growth of the market, for instance, in October 2020, Solentim announced the adoption of its VIPS single cell seeding platform and Cell Metric CLD into Samsung Biologics’ new research and development facility in San Francisco, CA. These instruments are designed for single cell cloning and assurance of monoclonality to increase the speed and efficiency of Master Cell Bank development. Samsung’s new R&D facility in San Francisco will offer rapid, high-quality development services, including cell line development, to its global customers. Solentim’s VIPS and Cell Metric CLD instruments will be used in conjunction with Samsung Biologics recently launched proprietary cell line platform, S-CHOice.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product Type
o By Source type
o By End User
o By Cell lines
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes, Advanced Instruments, Berkeley Lights, Boehringer Ingelheim International GmbH, Creative BioLabs., Danaher, Fujifilm Holdings Corp, Horizon Discovery Ltd., JSR Corp, Lonza, Merck KGaA Corning Inc., and others.
Key questions addressed by the Report.
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Cell Line Development Market Report Segment
By Product Type:
By Source Type:
By End User:
By Cell Lines:
Global Cell Line Development Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-line-development-market